For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Co-Diagnostics Inc (NASDAQ: CODX) closed the day trading at $0.25 down -8.89% from the previous closing price of $0.27. In other words, the price has decreased by -$8.89 from its previous closing price. On the day, 2.84 million shares were traded. CODX stock price reached its highest trading level at $0.2763 during the session, while it also had its lowest trading level at $0.2373.
Ratios:
For a better understanding of CODX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.51 and its Current Ratio is at 3.81. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CODX now has a Market Capitalization of 14985665 and an Enterprise Value of 5013820. For the stock, the TTM Price-to-Sale (P/S) ratio is 29.39 while its Price-to-Book (P/B) ratio in mrq is 0.30. Its current Enterprise Value per Revenue stands at 9.872 whereas that against EBITDA is -0.146.
Stock Price History:
The Beta on a monthly basis for CODX is 1.24, which has changed by -0.6280992 over the last 52 weeks, in comparison to a change of 0.16081822 over the same period for the S&P500. Over the past 52 weeks, CODX has reached a high of $1.55, while it has fallen to a 52-week low of $0.23. The 50-Day Moving Average of the stock is -36.52%, while the 200-Day Moving Average is calculated to be -28.94%.
Shares Statistics:
Over the past 3-months, CODX traded about 24.64M shares per day on average, while over the past 10 days, CODX traded about 1489910 shares per day. A total of 60.89M shares are outstanding, with a floating share count of 55.51M. Insiders hold about 8.84% of the company’s shares, while institutions hold 15.42% stake in the company. Shares short for CODX as of 1764288000 were 1138960 with a Short Ratio of 0.05, compared to 1761868800 on 2410821. Therefore, it implies a Short% of Shares Outstanding of 1138960 and a Short% of Float of 1.97.
Earnings Estimates
The market rating for Co-Diagnostics Inc (CODX) is a result of the insights provided by 2.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.12 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.68 and -$0.72 for the fiscal current year, implying an average EPS of -$0.7. EPS for the following year is -$0.41, with 2 analysts recommending between -$0.36 and -$0.45.
Revenue Estimates
2 analysts predict $126k in revenue for. The current quarter. It ranges from a high estimate of $150k to a low estimate of $102k. As of. The current estimate, Co-Diagnostics Inc’s year-ago sales were $149.33kFor the next quarter, 2 analysts are estimating revenue of $163.5k. There is a high estimate of $200k for the next quarter, whereas the lowest estimate is $127k.
A total of 2 analysts have provided revenue estimates for CODX’s current fiscal year. The highest revenue estimate was $509k, while the lowest revenue estimate was $460k, resulting in an average revenue estimate of $484.5k. In the same quarter a year ago, actual revenue was $3.92MBased on 2 analysts’ estimates, the company’s revenue will be $576k in the next fiscal year. The high estimate is $600k and the low estimate is $552k.
